Jury selection starts today in the first trial against Takeda alleging the diabetes drug Actos caused bladder cancer. There are more than 3,000 similar claims pending. The Plaintiff, Jack Cooper, is suffering with bladder cancer and alleges that Takeda’s U. S. unit didn’t adequlately warn potential patients that Actos could cause the disease. The FDA flagged the risk in a new analysis of an Actos trial, which suggested Actos patents faced increased risk of bladder cancer and heart problems. The FDA’s review is ongoing with results expected next year. The agency has already required new warning language on the drug’s label. The Cooper lawsuit is among a group of cases under reiview in the same California state court. Another 1,200 lawsuits are consolidated in an MDL in Louisiana. The first of those cases is set for trial in November 2014.